Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multi-metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00799461
What this trial is testing

Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+89 more
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1,337
Testing effectiveness (Phase 2)Looking for participantsNCT07226986
What this trial is testing

A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC

Who this might be right for
PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
Novartis Pharmaceuticals 123
Not applicableStudy completedNCT03219970
What this trial is testing

Efficacy and Safety of Osimertinib for HK Chinese With Metastatic T790M Mutated NSCLC-real World Setting.

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 156
Large-scale testing (Phase 3)Study completedNCT04229004
What this trial is testing

A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerMetastatic Pancreatic Adenocarcinoma
Pancreatic Cancer Action Network 502
Not applicableUnknownNCT03027544
What this trial is testing

Tomotherapy for Refractory Brain Metastases

Who this might be right for
Brain Metastases
Chinese Academy of Medical Sciences 150
Not applicableEnded earlyNCT02376933
What this trial is testing

Vertebral Augmentation and Radiotherapy of Collapse Spinal Metastatic Cancer

Who this might be right for
Metastatic CancersMultiple MyelomaVertebral Fracture
University of Arizona 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT06717126
What this trial is testing

A Randomised Phase II Study of Roginolisib in Patients With Advanced/Metastatic Uveal Melanoma

Who this might be right for
Uveal MelanomaOcular Melanoma
iOnctura 85
Not applicableEnded earlyNCT00008216
What this trial is testing

Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Adult Langerhans Cell HistiocytosisChildhood Langerhans Cell HistiocytosisLeukemia+4 more
Columbia University 48
Early research (Phase 1)Study completedNCT00039052
What this trial is testing

Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer

Who this might be right for
Breast CancerKidney CancerLung Cancer
Neurocrine Biosciences
Testing effectiveness (Phase 2)Ended earlyNCT03283826
What this trial is testing

Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis

Who this might be right for
Primary Progressive Multiple SclerosisSecondary Progressive Multiple Sclerosis
Atara Biotherapeutics 134
Early research (Phase 1)Study completedNCT02820454
What this trial is testing

Radiosensitization of Multiple Brain Metastases Using AGuIX Gadolinium Based Nanoparticles

Who this might be right for
Brain Metastases
University Hospital, Grenoble 15
Testing effectiveness (Phase 2)Looking for participantsNCT07127822
What this trial is testing

Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer

Who this might be right for
Gastric / Gastroesophageal Junction AdenocarcinomaMSI-H Cancer
Peking University 106
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07339839
What this trial is testing

Glecirasib Combined With Ivonescimab for First-line Treatment of KRAS G12C-mutated NSCLC

Who this might be right for
NSCLC Stage IVKRAS G12C
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 42
Early research (Phase 1)Ended earlyNCT06438783
What this trial is testing

TQB2928 Injection Combined Anlotinib Hydrochloride Capsule in Recurrent/Metastatic Osteosarcoma and Other Solid Tumors

Who this might be right for
OsteosarcomaOther Solid Tumors
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 20
Not applicableStudy completedNCT02527395
What this trial is testing

Association Between Heat Pain Detection Threshold and Area of Secondary Hyperalgesia

Who this might be right for
Healthy
Rigshospitalet, Denmark 121
Testing effectiveness (Phase 2)Study completedNCT03490032
What this trial is testing

68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa)

Who this might be right for
Prostate Cancer Metastatic
Advanced Accelerator Applications 30
Not applicableNot Yet RecruitingNCT07154914
What this trial is testing

A Novel Insight Into CRPC Progression and Immune: Evidence From Single-cell Spatial Transcriptome Multi-omics

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cance
Anhui Medical University 396
Not applicableLooking for participantsNCT06462963
What this trial is testing

OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)

Who this might be right for
Breast CancerProstate CancerNSCLC+2 more
European Organisation for Research and Treatment of Cancer - EORTC 302
Testing effectiveness (Phase 2)Looking for participantsNCT06378593
What this trial is testing

3HP-2827 in Treatment of Unresectable or Metastatic Solid Tumors With FGFR2 Alterations

Who this might be right for
Solid Tumors With FGFR2 Alterations, Adult
3H (Suzhou) Pharmaceuticals Co., Ltd. 130
Large-scale testing (Phase 3)Active Not RecruitingNCT03787992
What this trial is testing

Alflutinib Mesylate Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer （FLAG）

Who this might be right for
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung Cancer
Allist Pharmaceuticals, Inc. 358
Next Page